Kazakhstan vs South-East Asia (WHO region): Confirmed cases of MDR-TB
Kazakhstan
7,608
in 2012
South-East Asia (WHO region)
19,202
in 2012
Kazakhstan rank
4th
South-East Asia (WHO region) rank
5th
Confirmed cases of MDR-TB over time
- Kazakhstan
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 19,202 against 7,608 in Kazakhstan, a difference of 11,594.
That makes South-East Asia (WHO region)'s figure about 2.5 times Kazakhstan's.
The two have swapped places 1 time across 7 shared years of data; in 2006 it was Kazakhstan ahead.
Kazakhstan ranks 4th and South-East Asia (WHO region) ranks 5th of 145 countries.
Across the 2 decades both report, Kazakhstan averaged higher in 1 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Kazakhstan | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4,251 | 1,494 | 2,758 | Kazakhstan |
| 2010s | 7,468 | 9,920 | 2,452 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb, Kazakhstan or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 19,202 against 7,608 in Kazakhstan as of 2012.
- What is the difference in confirmed cases of mdr-tb between Kazakhstan and South-East Asia (WHO region)?
- 11,594, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for Kazakhstan and South-East Asia (WHO region)?
- 7 years are reported by both, from 2006 to 2012.
- How do Kazakhstan and South-East Asia (WHO region) rank globally for confirmed cases of mdr-tb?
- Kazakhstan ranks 4th and South-East Asia (WHO region) ranks 5th of 145 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.